The Atlantic gathered key stakeholders to examine the future for biosimilars domestically and abroad.
The Atlantic will convene experts for a discussion of the rare disease patient experience and why it is so unique.
We sat down with Atlantic senior editor James Hamblin to discuss his new book, If Our Bodies Could Talk: A Guide to Operating and Maintaining a Human Body, a handbook for tackling life’s most pressing health concerns and curiosities.
The Atlantic will gather key stakeholders to examine the emerging world of biosimilars and their regulatory framework in the United States.
The Secretary of Defense Ash Carter sat down with The Atlantic’s Editor in Chief Jeffrey Goldberg in a wide ranging conversation on the state of the US military, its role in the world and its future both home and abroad.